FR2873386B1 - Composition vaccinale contre le rhodococcus equi - Google Patents

Composition vaccinale contre le rhodococcus equi

Info

Publication number: FR2873386B1
Authority: FR; France
Prior art keywords: vaccine composition; composition against; rhodococcus equi; against rhodococcus; equi
Prior art date: 2004-07-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

FR0408136A

Other languages

English (en)

Other versions

FR2873386A1 (fr

Inventor

Said Taouji

Julien Cauchard

Jean Jacques Ballet

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Agence Francaise de Securite Sanitaire des Aliments (AFSSA)

Original Assignee

Agence Francaise de Securite Sanitaire des Aliments (AFSSA)

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-07-22

Filing date

2004-07-22

Publication date

2011-01-14

2004-07-22 Application filed by Agence Francaise de Securite Sanitaire des Aliments (AFSSA) filed Critical Agence Francaise de Securite Sanitaire des Aliments (AFSSA)

2004-07-22 Priority to FR0408136A priority Critical patent/FR2873386B1/fr

2005-07-12 Priority to US11/572,293 priority patent/US8052978B2/en

2005-07-12 Priority to EP05788683A priority patent/EP1769065A1/fr

2005-07-12 Priority to PCT/FR2005/001793 priority patent/WO2006021643A1/fr

2005-07-12 Priority to CA002574516A priority patent/CA2574516A1/fr

2006-01-27 Publication of FR2873386A1 publication Critical patent/FR2873386A1/fr

2011-01-14 Application granted granted Critical

2011-01-14 Publication of FR2873386B1 publication Critical patent/FR2873386B1/fr

2024-07-22 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Mycology (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

FR0408136A 2004-07-22 2004-07-22 Composition vaccinale contre le rhodococcus equi Expired - Lifetime FR2873386B1 (fr)

Priority Applications (5)

Application Number	Priority Date	Filing Date	Title
FR0408136A FR2873386B1 (fr)	2004-07-22	2004-07-22	Composition vaccinale contre le rhodococcus equi
US11/572,293 US8052978B2 (en)	2004-07-22	2005-07-12	Vaccine composition against Rhodococcus equi
EP05788683A EP1769065A1 (fr)	2004-07-22	2005-07-12	Composition vaccinale contre rhodococcus equi
PCT/FR2005/001793 WO2006021643A1 (fr)	2004-07-22	2005-07-12	Composition vaccinale contre rhodococcus equi
CA002574516A CA2574516A1 (fr)	2004-07-22	2005-07-12	Composition vaccinale contre rhodococcus equi

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0408136A FR2873386B1 (fr)	2004-07-22	2004-07-22	Composition vaccinale contre le rhodococcus equi

Publications (2)

Publication Number	Publication Date
FR2873386A1 FR2873386A1 (fr)	2006-01-27
FR2873386B1 true FR2873386B1 (fr)	2011-01-14

Family

ID=34947030

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR0408136A Expired - Lifetime FR2873386B1 (fr)	2004-07-22	2004-07-22	Composition vaccinale contre le rhodococcus equi

Country Status (5)

Country	Link
US (1)	US8052978B2 (fr)
EP (1)	EP1769065A1 (fr)
CA (1)	CA2574516A1 (fr)
FR (1)	FR2873386B1 (fr)
WO (1)	WO2006021643A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0919733D0 (en) *	2009-11-11	2009-12-30	Univ Edinburgh	Immune system modulating composition
IT201900014121A1 (it)	2019-08-06	2021-02-06	Univ Degli Studi Di Camerino	Marinomonas ef1 e rhodococcus ef1 per la produzione di metaboliti secondari

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4803070A (en)	1986-04-15	1989-02-07	Ribi Immunochem Research Inc.	Immunological emulsion adjuvants for polysaccharide vaccines
HU212924B (en)	1989-05-25	1996-12-30	Chiron Corp	Adjuvant formulation comprising a submicron oil droplet emulsion
AU667003B2 (en)	1993-01-08	1996-02-29	Csl Limited	Vaccine preparations
CA2125426A1 (fr) *	1994-06-08	1995-12-09	University Of Guelph	Sequence de gene de rhodococcus equi
GB9705588D0 (en)	1997-03-18	1997-05-07	Anglia Research Foundation	Stable particle in liquid formulations
DK1042001T3 (da)	1997-12-16	2002-07-08	Chiron Corp	Anvendelse af mikropartikler kombineret med submikron-(olie-i-vand)-emulsioner
US6630161B1 (en)	1998-05-07	2003-10-07	Ribi Immunochem Research, Inc.	Adjuvant composition and methods for its use
US6585973B1 (en)	1998-10-29	2003-07-01	Henry M. Jackson Foundation For The Advancement Of Military Medicine	Method for preparing solid phase conjugated vaccine
BR0008285A (pt) *	1999-02-18	2001-11-27	Rmf Dictagene Sa	Vacina contra malária, polipeptìdeo, e seus usos
CA2373239A1 (fr)	1999-05-20	2000-11-30	Pharmasol Gmbh	Adjuvant a stabilite et biocompatibilite optimisees pour l'augmentation de la reponse immunitaire humorale et cellulaire
EP1246645A2 (fr) *	1999-12-23	2002-10-09	Aphton Corporation	Composition immunogenique stable destinee a etre stockee congelee
FR2825276B1 (fr)	2001-05-31	2004-11-26	Seppic Sa	Adujvant d'immunite sous forme solide et vaccin le contenant
US20040038303A1 (en)	2002-04-08	2004-02-26	Unger Gretchen M.	Biologic modulations with nanoparticles

2004
- 2004-07-22 FR FR0408136A patent/FR2873386B1/fr not_active Expired - Lifetime
2005
- 2005-07-12 WO PCT/FR2005/001793 patent/WO2006021643A1/fr not_active Ceased
- 2005-07-12 EP EP05788683A patent/EP1769065A1/fr not_active Ceased
- 2005-07-12 US US11/572,293 patent/US8052978B2/en active Active
- 2005-07-12 CA CA002574516A patent/CA2574516A1/fr not_active Abandoned

Also Published As

Publication number	Publication date
WO2006021643A1 (fr)	2006-03-02
EP1769065A1 (fr)	2007-04-04
US8052978B2 (en)	2011-11-08
US20080008726A1 (en)	2008-01-10
CA2574516A1 (fr)	2006-03-02
FR2873386A1 (fr)	2006-01-27

Publication	Publication Date	Title
FR22C1008I2 (fr)	2024-01-19	Composition immunogène
IL192084A0 (en)	2008-12-29	Vaccine
GB0504436D0 (en)	2005-04-06	Vaccine
BRPI0809573A8 (pt)	2016-10-11	composição, e, método
GB0607088D0 (en)	2006-05-17	Vaccine
IL186828A0 (en)	2008-02-09	Vaccine composition
BRPI0814167A2 (pt)	2015-01-20	Composição, e, método
EP2019687A4 (fr)	2012-02-15	Vaccin anti-streptocoques
BRPI0807903A2 (pt)	2014-06-17	Composições medicinais melhoradas compreendendo buprenorfina e nalmefeno.
ZA200709207B (en)	2009-08-26	Vaccine
GB0810662D0 (en)	2008-07-16	Vaccine
FR2873386B1 (fr)	2011-01-14	Composition vaccinale contre le rhodococcus equi
GB0515135D0 (en)	2005-08-31	Vaccine
GB0516944D0 (en)	2005-09-28	Vaccine
ZA200709210B (en)	2009-04-29	Vaccine
GB0526412D0 (en)	2006-02-08	Vaccine
GB0503000D0 (en)	2005-03-16	Anti-atheroma vaccine
GB0513191D0 (en)	2005-08-03	Vaccine
IL186591A0 (en)	2008-01-20	Vaccine
GB0521164D0 (en)	2005-11-23	Vaccine
GB0515242D0 (en)	2005-08-31	Vaccine
GB0514021D0 (en)	2005-08-17	Vaccine
GB0509010D0 (en)	2005-06-08	Vaccine
GB0513189D0 (en)	2005-08-03	Vaccine
GB0513194D0 (en)	2005-08-03	Vaccine

Legal Events

Date	Code	Title	Description
2011-05-13	TP	Transmission of property
2016-07-28	PLFP	Fee payment	Year of fee payment: 13
2017-07-11	PLFP	Fee payment	Year of fee payment: 14
2018-07-16	PLFP	Fee payment	Year of fee payment: 15
2020-07-16	PLFP	Fee payment	Year of fee payment: 17
2021-06-22	PLFP	Fee payment	Year of fee payment: 18
2022-06-10	PLFP	Fee payment	Year of fee payment: 19
2023-06-14	PLFP	Fee payment	Year of fee payment: 20